LYRCX
Price
$31.76
Change
-$0.19 (-0.59%)
Updated
Jul 2 closing price
Net Assets
1.28B
VMVAX
Price
$103.69
Change
+$1.01 (+0.98%)
Updated
Jul 2 closing price
Net Assets
36.63B
Interact to see
Advertisement

LYRCX vs VMVAX

LYRCX vs VMVAX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 36.6B vs. LYRCX (1.28B). VMVAX pays higher dividends than LYRCX: VMVAX (1.88) vs LYRCX (0.00). LYRCX was incepted earlier than VMVAX: LYRCX (4 years) vs VMVAX (15 years). LYRCX (2.56) is less costly to investors than VMVAX (0.07). LYRCX is a more actively managed with annual turnover of: 32.00 vs. VMVAX (23.00). LYRCX has a lower initial minimum investment than VMVAX: LYRCX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 19.99 vs. LYRCX (12.54).
LYRCXVMVAXLYRCX / VMVAX
Total Expense Ratio1.990.072,843%
Annual Report Gross Expense Ratio2.560.073,657%
Fund Existence4 years15 years-
Gain YTD13.10512.951101%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B36.6B4%
Annual Yield % from dividends0.001.88-
Returns for 1 year12.5419.9963%
Returns for 3 years59.6244.66134%
Returns for 5 yearsN/A42.73-
Returns for 10 yearsN/A128.29-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNUSX22.670.47
+2.12%
JPMorgan Developed International Value L
OIEPX27.470.29
+1.07%
JPMorgan Equity Income R3
LVAEX29.570.15
+0.51%
LSV Value Equity Investor
RVVHX11.73-0.08
-0.68%
Royce Small-Cap Value Investment
RYOTX15.49-0.50
-3.13%
Royce Micro-Cap Invmt